RELATIONSHIP BETWEEN LANGUAGE-LITERACY SKILLS AND MENTAL HEALTH
RESEARCHER PROFILE (Filmed April 2024)
Associate Professor Amanda Neil
Select Foundation Principal Research Fellow
Menzies Institute for Medical Research
University of Tasmania &
Health Economics Lead,
Alive National Centre for Mental Health Research Translation
Australia
A/Prof Amanda Neil is a Select Foundation Principal Research Fellow, Menzies Institute for Medical Research, and the health economics lead for the ALIVE National Centre for Mental Health Research Translation. Amanda commenced work in the field of health economics in 1991, and has worked in academia, government and for industry. She was a Member of the Pharmaceutical Benefits Advisory Committee Economics Sub-Committee between 2000 and 2007.
Since commencing at Menzies in 2013, Amanda has established a research program focused on health services and systems, including innovative funding mechanisms and service provision within Tasmania. In 2019, Amanda established the Menzies Mental Health and Wellbeing Research Group to support university and sector wide mental health research in Tasmania. These efforts now include a collaboration with the recently established Tasmanian Centre for Mental Health Service Innovation, including on the current project.
In an innovative move towards enhancing mental health services, Associate Professor Amanda Neil and team, supported by the RHH Research Foundation, are undertaking a crucial study on language-literacy skills of patients within mental health care settings. This year-long project, which commenced in April 2024, seeks to unravel to what extent, where and for whom language-literacy skills are being considered in Tasmanian mental health service provision.
The current project is one Amanda is very passionate about, given her own experience as the mum of a child who experienced significant delays in learning to speak, read and write. This experience leading to her involvement in the 2017 and 2018 Heart of Literacy Symposiums led by 2017 Tasmanian of the Year, Ms Rosalie Martin. Subsequently, A/Prof Isabelle Bartkowiak-Theron, Tasmanian Institute of Law Enforcement and Amanda received philanthropic funding to establish a research program on language-literacy as a social determinant of health and a pathway to resilience and desistence. The current project is extending this foundational work into the domain of mental health service provision.
-
Neonatal respiratory trials in sick & preterm newborn infants
Prof Brett J. Manley leads and collaborates on large national and international randomised clinical trials in neonatology. He previously collaborated on 4 randomised trials of nasal high-flow as non-invasive respiratory support for preterm and term infants, all of which were published in N Engl J Med. Recently he led the PLUSS trial of intratracheal budesonide for extremely preterm infants, that recruited in 21 NICUs across 4 countries, the results of which were published in JAMA. PLUSS was awarded the Australian Clinical Trials Alliance Trial of the Year in 2025. Another passion of his is mentoring and supervising early career researchers to undertake their own clinical trials.
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
Biomarkers for early sepsis detection
Dr Gabrielle Briggs is a biomedical scientist dedicated to finding smarter, faster ways to diagnose and treat life threatening complications in critically ill patients. Dr Briggs established a research laboratory embedded within the John Hunter Hospital – one of the busiest major trauma centres in NSW. Dr Briggs works alongside surgeons, intensivists, and pathologists to turn complex clinical problems into practical research solutions. Her work spans two major programs: developing a rapid diagnostic test to detect bacterial infections in blood before sepsis takes hold, and exploring mitochondrial transplantation as a novel therapy to rescue injured tissues after trauma and ischaemia.
